FAM167B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.100200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.216600E-01
Normal-vs-Stage2
7.705400E-01
Normal-vs-Stage3
6.992400E-01
Normal-vs-Stage4
9.585800E-01
Stage1-vs-Stage2
5.706800E-01
Stage1-vs-Stage3
7.898400E-01
Stage1-vs-Stage4
5.585200E-01
Stage2-vs-Stage3
7.160400E-01
Stage2-vs-Stage4
7.946600E-01
Stage3-vs-Stage4
5.796000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.059600E-01
Normal-vs-AfricanAmerican
6.764600E-01
Normal-vs-Asian
8.966000E-01
Caucasian-vs-AfricanAmerican
9.361800E-01
Caucasian-vs-Asian
6.310800E-01
AfricanAmerican-vs-Asian
6.129600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.048200E-01
Normal-vs-Female
5.400600E-01
Male-vs-Female
2.454300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.805400E-01
Normal-vs-Age(41-60Yrs)
6.034600E-01
Normal-vs-Age(61-80Yrs)
8.449600E-01
Normal-vs-Age(81-100Yrs)
6.202200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.994800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.030000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.639000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.257760E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.596400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.611600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.940400E-01
Normal-vs-Daily Drinker
6.898800E-01
Normal-vs-Weekly Drinker
6.039800E-01
Normal-vs-Occasional Drinker
8.350600E-01
Normal-vs-Social Drinker
9.680000E-01
Non Drinker-vs-Daily Drinker
5.640800E-01
Non Drinker-vs-Weekly Drinker
3.800200E-01
Non Drinker-vs-Occasional Drinker
8.992000E-01
Non Drinker-vs-Social Drinker
6.685000E-01
Daily Drinker-vs-Weekly Drinker
7.837000E-01
Daily Drinker-vs-Occasional Drinker
5.344200E-01
Daily Drinker-vs-Social Drinker
4.452600E-01
Weekly Drinker-vs-Occasional Drinker
4.152800E-01
Weekly Drinker-vs-Social Drinker
3.214600E-01
Occasional Drinker-vs-Social Drinker
7.643600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.041200E-01
Normal-vs-Grade 2
6.614000E-01
Normal-vs-Grade 3
6.135800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.440400E-01
Grade 1-vs-Grade 3
1.015640E-01
Grade 1-vs-Grade 4
7.041200E-01
Grade 2-vs-Grade 3
1.265750E-01
Grade 2-vs-Grade 4
6.614000E-01
Grade 3-vs-Grade 4
6.135800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.667400E-01
Normal-vs-NonDiabetic
6.985600E-01
Diabetic-vs-NonDiabetic
6.779200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.723800E-01
Normal-vs-NoPancreatitis
7.063000E-01
Pancreatitis-vs-NoPancreatitis
2.872600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.539200E-01
Normal-vs-N1
7.305600E-01
N0-vs-N1
9.391800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.437600E-01
Normal-vs-TP53-NonMutant
7.972000E-01
TP53-Mutant-vs-TP53-NonMutant
5.981200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
